Path: ...!news.roellig-ltd.de!open-news-network.org!weretis.net!feeder8.news.weretis.net!eternal-september.org!feeder3.eternal-september.org!news.eternal-september.org!.POSTED!not-for-mail
From: Tom Kunich <cyclintom@yahoo.com>
Newsgroups: rec.bicycles.tech
Subject: Re: Abbott
Date: Fri, 18 Oct 2024 21:57:03 -0000 (UTC)
Organization: A noiseless patient Spider
Lines: 17
Message-ID: <veuljf$3g3j5$2@dont-email.me>
References: <vc4rhl$1ll0k$1@dont-email.me>
	<cfmcejtbbuul24ed1aga4ld5n7ghid2irr@4ax.com>
	<R0DFO.50985$WtV9.20966@fx10.iad> <cVHFO.102852$WOde.47797@fx09.iad>
	<vc84cr$2iorr$1@dont-email.me> <Q3UKO.370788$WOde.248681@fx09.iad>
	<vdh992$2qfmg$1@dont-email.me> <ve1c0b$1qp84$1@dont-email.me>
	<ve1g9d$1mrpv$23@dont-email.me> <ve6898$2molh$2@dont-email.me>
	<ve69ae$2mp8v$1@dont-email.me> <ve6dtv$2nnrk$2@dont-email.me>
	<ve6kls$2oihr$4@dont-email.me> <veuiu4$3e3et$1@dont-email.me>
	<0vj5hjh4f6igpdv951ciksrt3ac4ohkq50@4ax.com>
MIME-Version: 1.0
Content-Type: text/plain; charset=UTF-8
Content-Transfer-Encoding: 8bit
Injection-Date: Fri, 18 Oct 2024 23:57:03 +0200 (CEST)
Injection-Info: dont-email.me; posting-host="bb35ba375542d49dce900c16df6f2af2";
	logging-data="3673701"; mail-complaints-to="abuse@eternal-september.org";	posting-account="U2FsdGVkX19AwFhIbCkFI24oxVWAjk9BXGas6ICwf0Q="
User-Agent: Pan/0.146 (Hic habitat felicitas; d7a48b4
 gitlab.gnome.org/GNOME/pan.git)
Cancel-Lock: sha1:5Ce+C6G5VbrPcG/6WshFUHLMK+0=
Bytes: 2135

On Fri, 18 Oct 2024 18:19:46 -0300, Shadow wrote:

> On Fri, 18 Oct 2024 21:11:32 -0000 (UTC), Tom Kunich
> <cyclintom@yahoo.com> wrote:
> 
>>even thugh they manufacture an epipen, they buy insulin elsewhere to
>>fill it with.
> 
> 	I hope Abbott is NOT filling epipens with insulin.
> 	If they are, here's your chance to get rich. Sue them.
> 	[]'s

Is this more of your Texas Tax laws misinformation? And epipen can be 
specified for various conditions from treating people with hyperallergic 
reactions to people needing a type in case of being diabetic and getting 
too much glucose and reacting to it.